A NEW APPROACH TO THE ANALYSIS OF CLINICAL DRUG TRIALS WITH WITHDRAWALS

被引：89
作者：
GOULD, AL
机构：
来源：
BIOMETRICS | 1980年 / 36卷 / 04期
关键词：
D O I：
10.2307/2556126
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：721 / 727
页数：7
相关论文
共 16 条
[11]   DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES [J].
PETO, R ;
PIKE, MC ;
ARMITAGE, P ;
BRESLOW, NE ;
COX, DR ;
HOWARD, SV ;
MANTEL, N ;
MCPHERSON, K ;
PETO, J ;
SMITH, PG .
BRITISH JOURNAL OF CANCER, 1977, 35 (01) :1-39
[12]   DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .1. INTRODUCTION AND DESIGN [J].
PETO, R ;
PIKE, MC ;
ARMITAGE, P ;
BRESLOW, NE ;
COX, DR ;
HOWARD, SV ;
MANTEL, N ;
MCPHERSON, K ;
PETO, J ;
SMITH, PG .
BRITISH JOURNAL OF CANCER, 1976, 34 (06) :585-612
[13]   ANALYSIS OF FAILURE TIMES IN PRESENCE OF COMPETING RISKS [J].
PRENTICE, RL ;
KALBFLEISCH, JD ;
PETERSON, AV ;
FLOURNOY, N ;
FAREWELL, VT ;
BRESLOW, NE .
BIOMETRICS, 1978, 34 (04) :541-554
[14]   SIGNIFICANCE TEST FOR SIMULTANEOUS QUANTAL + QUANTITATIVE RESPONSES [J].
WEILER, H .
TECHNOMETRICS, 1964, 6 (03) :273-&
[15]  
1978, FDA DRUG B, V8, P19
[16]  
1975, DIABETES S1, V24, P65
12